Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brocard

Showing results (391-400 of 455) with videos related to

Pageof 46
Sort By:
JAMA Dermatology|August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in FranceDragos Ciocan, Coralie Barbe, Francois Aubin, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Functional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 ProteinMarine Cacheux, Ariane Blum, Muriel Sébastien, et al.
Human Gene Therapy|June 29, 2013
Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathyJohn Rendu, Julie Brocard, Eric Denarier, et al.
Transplantation|January 19, 2017
Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 CasesEmilie Ducroux, Clemmie Martin, Jan Nico Bouwes Bavinck, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
FEBS Letters|February 13, 2001
Disulfide bridge reorganization induced by proline mutations in maurotoxinE Carlier, Z Fajloun, P Mansuelle, et al.
Breast (Edinburgh, Scotland)|November 14, 2020
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA studyAnne-Claire Hardy-Bessard, Fabien Brocard, Florian Clatot, et al.
The British Journal of Dermatology|October 7, 2009
Management and outcome of metastatic melanoma during pregnancyC Pagès, C Robert, L Thomas, et al.
Brain Research Reviews|October 6, 2007
Initiation of locomotion in lampreysRéjean Dubuc, Frédéric Brocard, Myriam Antri, et al.
Acta Neuropathologica Communications|November 12, 2020
In vivo RyR1 reduction in muscle triggers a core-like myopathyLaurent Pelletier, Anne Petiot, Julie Brocard, et al.
Pageof 46

Showing results (391-400 of 455) with videos related to

Sort By:
Pageof 46
JAMA Dermatology|August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in FranceDragos Ciocan, Coralie Barbe, Francois Aubin, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Functional Characterization of a Central Core Disease RyR1 Mutation (p.Y4864H) Associated with Quantitative Defect in RyR1 ProteinMarine Cacheux, Ariane Blum, Muriel Sébastien, et al.
Human Gene Therapy|June 29, 2013
Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathyJohn Rendu, Julie Brocard, Eric Denarier, et al.
Transplantation|January 19, 2017
Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 CasesEmilie Ducroux, Clemmie Martin, Jan Nico Bouwes Bavinck, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depressionEveline Jaquenoud Sirot, Sabine Harenberg, Pierre Vandel, et al.
FEBS Letters|February 13, 2001
Disulfide bridge reorganization induced by proline mutations in maurotoxinE Carlier, Z Fajloun, P Mansuelle, et al.
Breast (Edinburgh, Scotland)|November 14, 2020
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA studyAnne-Claire Hardy-Bessard, Fabien Brocard, Florian Clatot, et al.
The British Journal of Dermatology|October 7, 2009
Management and outcome of metastatic melanoma during pregnancyC Pagès, C Robert, L Thomas, et al.
Brain Research Reviews|October 6, 2007
Initiation of locomotion in lampreysRéjean Dubuc, Frédéric Brocard, Myriam Antri, et al.
Acta Neuropathologica Communications|November 12, 2020
In vivo RyR1 reduction in muscle triggers a core-like myopathyLaurent Pelletier, Anne Petiot, Julie Brocard, et al.
Pageof 46